Dinalgen 150mg/ml Injection 100ml stands out as a powerful and indispensable pharmaceutical tool, particularly in equines, cattle, and swine. This highly concentrated injectable solution offers veterinarians a reliable means to combat acute and chronic conditions characterized by significant discomfort and inflammatory responses.

What is Dinalgen 150mg/ml Injection 100ml?

Dinalgen 150mg/ml Injection 100ml is a veterinary Non-Steroidal Anti-Inflammatory Drug (NSAID). The active ingredient in Dinalgen is Flunixin Meglumine, a renowned and potent NSAID celebrated for its strong analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties.

The “150mg/ml” concentration signifies a highly robust formulation. This higher concentration, compared to more standard 50mg/ml flunixin products, allows for smaller injection volumes, which is particularly advantageous in large animal practices. Smaller volumes minimize tissue irritation and stress during administration, making it a more convenient option for both the animal and the handler. The “100ml” presentation indicates a multi-dose vial, making it an economical and practical choice for busy veterinary clinics and farms.

How it Works: The Mechanism of Action

Flunixin Meglumine, the active component of Dinalgen, exerts its therapeutic effects by inhibiting the cyclooxygenase (COX) enzymes. These enzymes are pivotal in the synthesis of prostaglandins, which are key chemical mediators involved in:

• Inflammation: Prostaglandins cause vasodilation, increased vascular permeability, and recruit inflammatory cells.
• Pain: They sensitize nerve endings to painful stimuli.
• Fever: They act on the hypothalamus to elevate the body’s set point, leading to fever.

By blocking the COX enzymes, Dinalgen 150mg/ml Injection effectively reduces the production of these prostaglandins. This leads to:

• Potent Analgesia: Particularly effective against visceral pain (e.g., in colic) and pain associated with inflammation.
• Strong Anti-inflammatory Action: Rapidly reduces swelling, heat, redness, and loss of function at inflammatory sites.
• Effective Antipyresis: Swiftly lowers elevated body temperatures.

Flunixin Meglumine is considered a non-selective COX inhibitor, meaning it inhibits both COX-1 and COX-2 enzymes. This broad action contributes to its powerful effects but also necessitates careful consideration of its side effect profile.

Key Clinical Indications

• Horses:
  • Colic: Its primary indication. Flunixin is highly effective for the alleviation of visceral pain associated with various forms of colic, providing rapid and sustained relief. It helps to stabilize the horse while the underlying cause is diagnosed and treated.
  • Musculoskeletal Disorders: For acute and chronic lameness, osteoarthritis, tendinitis, and myositis.
  • Ophthalmic Conditions: Used to control pain and inflammation associated with uveitis and other eye conditions.
  • Post-Operative Pain: To manage pain and inflammation following surgical procedures.
• Cattle:
  • Bovine Respiratory Disease (BRD): Used as an adjunctive therapy with antibiotics to reduce fever, lung inflammation, and pain, significantly improving the animal’s comfort and encouraging feed intake.
  • Acute Mastitis: Effectively alleviates systemic pain, reduces udder inflammation, and lowers fever when used alongside appropriate antibiotic treatment.
  • Endotoxemia: Critical in managing the systemic inflammatory response and shock associated with bacterial infections and endotoxin release (e.g., severe mastitis, metritis).
  • Lameness: For pain and inflammation related to various foot and joint conditions.
• Swine:
  • Porcine Respiratory Disease Complex: Used as an antipyretic and anti-inflammatory to improve animal comfort.
  • Mastitis-Metritis-Agalactia (MMA) Syndrome: In sows, it helps alleviate pain and inflammation, supporting the sow’s recovery and fostering nursing behavior.
  • Lameness: For pain and inflammation associated with locomotor disorders.

Administration and Dosage

Dinalgen 150mg/ml Injection is typically administered via intravenous (IV) or intramuscular (IM) injection, depending on the species and the specific condition being treated. For horses, IV administration often provides the fastest onset of action, which is critical in colic cases.

Precise dosing, calculated based on the animal’s exact body weight, the severity of the condition, and the species-specific guidelines, is paramount. The high concentration of 150mg/ml means that a smaller volume is needed per dose, which is a practical advantage. It is often prescribed as a single dose or a short course of therapy.

Safety, Precautions, and Withdrawal Times

• Gastrointestinal Effects: Like other NSAIDs, it can cause gastrointestinal irritation, ulceration, or bleeding, especially with prolonged use, high doses, or in susceptible animals.
• Renal Toxicity: Can impair kidney function, particularly in dehydrated animals, those with pre-existing renal disease, or very young/old animals. Adequate hydration is critically important before and during treatment.
• Bleeding Disorders: It can inhibit platelet aggregation, potentially increasing bleeding times.
• Pregnancy and Lactation: Use in pregnant animals should be approached with extreme caution, as NSAIDs can impact fetal development or prolong gestation. Consult the product label for specific warnings regarding each species.
• Concomitant Use: Should not be used concurrently with other NSAIDs or corticosteroids due to a significantly increased risk of adverse effects.
• Intra-arterial Injection: Accidental intra-arterial injection, especially in horses, can cause serious adverse reactions including ataxia, muscle weakness, and recumbency.